Safety and tolerability of the novel non-steroidal mineralocorticoid receptor antagonist BAY 94-8862 in patients with chronic heart failure and mild or moderate chronic kidney disease: a randomized, double-blind trial - Pitt, B; Kober, L; Ponikowski, P (Eur Heart J, 2013)
et al.